Header cover image

U.S. Pharma Industry Analysis

UpdatedNov 09, 2024
DataAggregated Company Financials
Companies295
  • 7D-0.1%
  • 3M-3.7%
  • 1Y17.1%
  • YTD10.2%

Over the last 7 days, the Pharma industry has remained flat. As for the the longer term, the industry is up 17% over the past 12 months. Earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 10 Nov 2024US$1.9tUS$373.6bUS$30.3b21.7x61.7x5x
Tue, 08 Oct 2024US$2.0tUS$364.1bUS$25.2b18.4x78.5x5.4x
Thu, 05 Sep 2024US$2.1tUS$364.1bUS$25.5b18x81.1x5.7x
Sat, 03 Aug 2024US$1.9tUS$359.5bUS$22.2b16.1x87.2x5.4x
Mon, 01 Jul 2024US$1.9tUS$357.6bUS$13.8b16.1x140.9x5.4x
Wed, 29 May 2024US$1.9tUS$358.3bUS$14.1b16x133.3x5.2x
Fri, 26 Apr 2024US$1.8tUS$359.5bUS$17.5b21.9x101.6x5x
Sun, 24 Mar 2024US$1.9tUS$355.3bUS$22.6b19.8x82.6x5.3x
Tue, 20 Feb 2024US$1.9tUS$355.0bUS$23.9b28.3x79.4x5.4x
Thu, 18 Jan 2024US$1.8tUS$375.2bUS$33.9b27.6x51.7x4.7x
Sat, 16 Dec 2023US$1.6tUS$375.1bUS$33.9b26.7x48.6x4.4x
Mon, 13 Nov 2023US$1.6tUS$375.5bUS$34.1b26.5x47.6x4.3x
Wed, 11 Oct 2023US$1.7tUS$381.8bUS$43.8b18.1x38.6x4.4x
Fri, 08 Sep 2023US$1.8tUS$381.8bUS$43.9b19.3x41.3x4.7x
Sun, 06 Aug 2023US$1.7tUS$379.8bUS$43.1b21.5x39.1x4.4x
Tue, 04 Jul 2023US$1.7tUS$392.8bUS$60.2b18.6x29x4.4x
Thu, 01 Jun 2023US$1.7tUS$393.0bUS$60.6b17.8x27.7x4.3x
Sat, 29 Apr 2023US$1.7tUS$400.2bUS$62.2b17.4x27x4.2x
Mon, 27 Mar 2023US$1.6tUS$401.2bUS$69.5b14.7x22.3x3.9x
Wed, 22 Feb 2023US$1.6tUS$401.7bUS$68.4b17.9x23.6x4x
Fri, 20 Jan 2023US$1.7tUS$403.7bUS$70.6b17.7x23.9x4.2x
Sun, 18 Dec 2022US$1.7tUS$403.7bUS$70.7b16.7x24.6x4.3x
Tue, 15 Nov 2022US$1.7tUS$403.6bUS$71.1b12.9x24x4.2x
Thu, 13 Oct 2022US$1.6tUS$403.0bUS$71.3b12.2x21.8x3.9x
Sat, 10 Sep 2022US$1.6tUS$403.0bUS$71.3b14x22.5x4x
Mon, 08 Aug 2022US$1.6tUS$403.3bUS$69.5b19.3x23.5x4.1x
Wed, 06 Jul 2022US$1.7tUS$392.4bUS$65.1b22.1x26x4.3x
Fri, 03 Jun 2022US$1.7tUS$392.5bUS$64.8b21.5x25.7x4.2x
Sun, 01 May 2022US$1.6tUS$380.0bUS$61.3b20.5x26.7x4.3x
Tue, 29 Mar 2022US$1.7tUS$373.8bUS$60.4b22.2x27.4x4.4x
Thu, 24 Feb 2022US$1.5tUS$373.4bUS$59.2b20.8x25.4x4x
Sat, 22 Jan 2022US$1.6tUS$361.3bUS$37.7b22.8x41.4x4.3x
Mon, 20 Dec 2021US$1.6tUS$361.1bUS$38.1b22.6x42.9x4.5x
Wed, 17 Nov 2021US$1.6tUS$360.6bUS$38.5b24.1x41.4x4.4x
Price to Earnings Ratio

41.4x


Total Market Cap: US$1.6tTotal Earnings: US$38.5bTotal Revenue: US$360.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Pharma Industry Price to Earnings3Y Average 49.1x202220232024
Current Industry PE
  • Investors are optimistic on the American Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 61.7x which is higher than its 3-year average PE of 49.1x.
  • The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 7.7% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market5.03%
Healthcare2.10%
Pharma-0.12%
Pharma-0.12%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LLY Eli LillyUS$831.541.5%
+US$12.3b
39.1%PE89.5x
MRK MerckUS$102.921.0%
+US$2.1b
1.5%PE21.4x
VTRS ViatrisUS$12.9611.5%
+US$1.6b
40.9%PS1x
CORT Corcept TherapeuticsUS$59.6025.2%
+US$1.3b
138.1%PE44.4x
ELAN Elanco Animal HealthUS$14.0711.7%
+US$727.0m
31.7%PE33.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MRK

US$102.92

Merck

7D

1.0%

1Y

1.5%

ELAN

US$14.07

Elanco Animal Health

7D

11.7%

1Y

31.7%

VTRS

US$12.96

Viatris

7D

11.5%

1Y

40.9%

JNJ

US$155.47

Johnson & Johnson

7D

-2.9%

1Y

5.6%

JAZZ

US$123.61

Jazz Pharmaceuticals

7D

11.9%

1Y

2.8%

TEVA

US$17.11

Teva Pharmaceutical Industries

7D

-7.3%

1Y

97.1%

CORT

US$59.60

Corcept Therapeutics

7D

25.2%

1Y

138.1%

LLY

US$831.54

Eli Lilly

7D

1.5%

1Y

39.1%

OGN

US$16.04

Organon

7D

-11.2%

1Y

44.2%

ZTS

US$176.82

Zoetis

7D

-2.8%

1Y

4.4%

BMY

US$54.14

Bristol-Myers Squibb

7D

-0.3%

1Y

7.0%